NCT01069354

Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds

Evaluation of Pain With the Use of Radiesse® With Lidocaine for the Treatment of Nasolabial Folds

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 102 (actual)
• Sponsor: Merz North America, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To assess pain during nasolabial fold treatment using Radiesse® Injectable Dermal Filler with lidocaine

Detailed description

To assess pain immediately after nasolabial fold treatment with Radiesse® Injectable Dermal Filler with lidocaine in one nasolabial fold compared to Radiesse® Injectable Dermal Filler without lidocaine in the contralateral nasolabial fold

Conditions

• Nasolabial Folds

Interventions

Type	Name	Description
DEVICE	Radiesse® Injectable Dermal Filler with Lidocaine	Calcium hydroxylapatite particles suspended in an aqueous-based gel carrier with 3% lidocaine hydrochloride (HCl)
DEVICE	Radiesse® Injectable Dermal Filler without Lidocaine	Calcium hydroxylapatite particles suspended in an aqueous-based gel carrier without 3% lidocaine hydrochloride (HCl)

Timeline

• Start date: 2012-11-01
• Primary completion: 2013-05-01
• Completion: 2014-02-01
• First posted: 2010-02-17
• Last updated: 2018-05-30
• Results posted: 2018-05-30

Locations

2 sites across 1 country: Canada